BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2016
View Archived Issues
Novel small molecule selected for clinical development to treat spinal muscular atrophy
Read More
BGP-15 improves ventilation-induced diaphragm dysfunction in preclinical model
Read More
Takeda Pharmaceutical reports MGAT2 inhibitors
Read More
Merck & Co. patents potassium channel blockers
Read More
Inhibition of RIPK1 kinase as axonal protective strategy in human degenerative disease
Read More
LOX-1 is a specific marker of human PMN-MDSCs in cancer patients
Read More
Novel DNA vaccines provide enhanced protection from Pseudomonas aeruginosa in mice
Read More
Navigen receives SBIR award to support the development of its anti-RSV compound
Read More
UPCI announces NCI grants for early detection of cancer
Read More
AdAlta raises AUD 10 million to accelerate new therapies for lung fibrosis
Read More
FDA grants orphan drug designation to dusquetide
Read More
Keystone's ceramide is given FDA orphan drug designation
Read More
Aurinia reports promising findings from phase IIb study of voclosporin in active lupus nephritis
Read More
Aveo Oncology initiates phase I/II trial of tivozanib
Read More
Novadigm Therapeutics discloses positive data from phase IIa trial
Read More
Bristol-Myers Squibb initiates phase I trial of BMS-986166 in healthy volunteers
Read More
Sanofi announces public dengue immunization program in Brazil with Dengvaxia
Read More
Zimmer Biomet announces acquisition of CD Diagnostics
Read More
Bavarian Nordic signs drug supply agreement with Bristol-Myers Squibb for the supply of Opdivo
Read More
Celsion reports updated results on its HEAT phase III trial
Read More
Vertex updates status of phase III program of VX-661 with ivacaftor for cystic fibrosis
Read More
AcelRx's phase III trial of ARX-04 in emergency room patients meets primary endpoint
Read More
AstraZeneca and Leo Pharma complete tralokinumab licensing agreement
Read More
Six-month update on Repros' study of enclomiphene in obese secondary hypogonadal men
Read More
FDA accepts Checkpoint Therapeutics' IND for CK-101
Read More